Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Penumbra Inc before investing.

In this article, we go over a few key elements for understanding Penumbra Inc’s stock price such as:

• Penumbra Inc’s current stock price and volume
• Why Penumbra Inc’s stock price changed recently
• Upgrades and downgrades for PEN from analysts
• PEN’s stock price momentum as measured by its relative strength

About Penumbra Inc (PEN)

Before we jump into Penumbra Inc’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Penumbra, Inc. is a healthcare company. The Company designs, develops, manufactures, and markets products and has a portfolio that addresses challenging medical conditions in markets with unmet need. It is focused on developing, manufacturing, and marketing products for use by specialist physicians and healthcare providers to drive improved clinical and health outcomes. It is focused on developing and building its portfolio of products, including its thrombectomy, embolization, access, and immersive healthcare technologies. Common conditions that the Company focuses on Pulmonary Embolism, Deep Vein Thrombosis, Peripheral Arterial Occlusion, Ischemic Stroke, Acute Coronary Syndrome, Clot associated with Arteriovenous Graft or Fistula, Aneurysm, and Hemorrhagic Stroke. The Company sells its products to healthcare providers primarily through its direct sales organization in the United States, Europe, Canada and Australia, as well as through distributors in select international markets.

Want to learn more about Penumbra Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Penumbra Inc.

Penumbra Inc’s Stock Price as of Market Close

As of September 10, 2024, 4:00 PM, CST, Penumbra Inc’s stock price was $204.12.

Penumbra Inc is up 4.63% from its previous closing price of $195.08.

During the last market session, Penumbra Inc’s stock traded between $194.86 and $204.80. Currently, there are 38.79 million shares of Penumbra Inc stock available for purchase.

Penumbra Inc’s price-earnings (P/E) ratio is currently at 571.2, which is high compared to the Medical Equipment, Supplies & Distribution industry median of 40.5. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Penumbra Inc Stock Price History

Penumbra Inc’s (PEN) price is currently up 0.89% so far this month.

During the month of September, Penumbra Inc’s stock price has reached a high of $209.68 and a low of $194.78.

Over the last year, Penumbra Inc has hit prices as high as $302.00 and as low as $148.00. Year to date, Penumbra Inc’s stock is down 8.24%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Penumbra Inc Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. However, as of September 09, 2024,, no analysts have changed their rating of Penumbra Inc’s stock over the last month.

Additionally, you'll want to evaluate Penumbra Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Penumbra Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Penumbra Inc’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Penumbra Inc (PEN) by visiting AAII Stock Evaluator.

Relative Price Strength of Penumbra Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of September 09, 2024, Penumbra Inc has a weighted four-quarter relative price strength of -10.27%, which translates to a Momentum Score of 31 and is considered to be Weak.

Want to learn more about how Penumbra Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Penumbra Inc Stock Price: Bottom Line

As of September 10, 2024, Penumbra Inc’s stock price is $204.12, which is up 4.63% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Penumbra Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.